NCT01183793

Brief Summary

It is essential to know intestinal length and anastomotic type in post-operative short bowel syndrome patients. These parameters can help predict long-term intestinal failure with long-term parenteral nutrition usually needed for smallest lengths. Sometimes these parameters are unfortunately missing for lack of intraoperative measurement. Thus, it is necessary to develop non-invasive and reproducible techniques to assess small bowel length. This is the reason why the investigators will evaluate magnetic resonance (MR)-enterography and barium follow-through in this indication. There are at this time only two small studies evaluating barium follow-through for intestinal length measurement, and none evaluating MR-enterography. However, a major advantage of the latter is the lack of radiation exposure and possibility to perform 3D. This will be an open labelled single center crossover study. Short bowel syndrome patients of the investigators center will be included after consent. The sequence of exams (MR enterography followed by barium follow-through or vice-versa) will be randomly assigned. Peroperative short bowel length measurement will be available for all patients. There will be one month between the two exams. The main objective of this study is to assess the performance of MR-enterography in short bowel measurement in short bowel syndrome patients, the gold standard being peroperative length. Secondary objectives are to assess the performance of barium follow-through in short bowel measurement in these patients, and to show that barium follow-through does not perform better than MR-enterography. For that purpose the investigators will include 50 patients over 2 years.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2010

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2010

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

August 2, 2010

Completed
16 days until next milestone

First Posted

Study publicly available on registry

August 18, 2010

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2010

Completed
1.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2012

Completed
Last Updated

August 18, 2010

Status Verified

June 1, 2010

Enrollment Period

3 months

First QC Date

August 2, 2010

Last Update Submit

August 17, 2010

Conditions

Keywords

Gastrointestinal Tract [A03.556]

Outcome Measures

Primary Outcomes (1)

  • Assessment of the lack of difference between surgical and MR enterography small bowel length measurement with a comparison sample test

    at 3 months

Secondary Outcomes (1)

  • Assessment of the lack of difference between surgical and barium follow through small bowel length measurement with a comparison sample test

    at 3 months

Study Arms (2)

Bras pair

OTHER

MR-enterography then barium follow through

Radiation: Barium follow-through and MR-enterography

Bras impair

OTHER

Barium follow-through then MR-enterography

Radiation: Barium follow-through and MR-enterography

Interventions

Assessment of the lack of difference between surgical and MR enterography small bowel length measurement with a comparison sample test

Bras impairBras pair

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Intraoperative small bowel length \< 200 cm
  • Males and females between 18 and 85 years of age
  • Patient with social insurance
  • Signature of informed consent

You may not qualify if:

  • Allergy to contrast product
  • Enterostomy closure expected within 2 months after randomization
  • Pregnancy or breast feeding woman
  • Swallowing disorders
  • Deprivation of liberty
  • Contraindications to magnetic resonance imaging (pace-maker, metal implant, known allergy to gadolinium)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service d'Hépato-Gastroentérologie et Nutrition Clinique - CHU Nice - hôpital Archet 2

Nice, 06000, France

RECRUITING

MeSH Terms

Conditions

Short Bowel Syndrome

Condition Hierarchy (Ancestors)

Malabsorption SyndromesIntestinal DiseasesGastrointestinal DiseasesDigestive System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • SCHNEIDER Stephane, PU-PH

    Services d'Hépato-Gastroentérologie et Nutrition Clinique

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
DIAGNOSTIC
Intervention Model
CROSSOVER
Sponsor Type
OTHER

Study Record Dates

First Submitted

August 2, 2010

First Posted

August 18, 2010

Study Start

July 1, 2010

Primary Completion

October 1, 2010

Study Completion

July 1, 2012

Last Updated

August 18, 2010

Record last verified: 2010-06

Locations